SIMCARD

This brand name is authorized in Hong Kong SAR China, South Africa.

Active ingredients

The drug SIMCARD contains one active pharmaceutical ingredient (API):

1	Simvastatin UNII AGG2FN16EV - SIMVASTATIN
	Simvastatin has a potent activity in inhibiting HMG-CoA reductase (3-hydroxy–3-ethylglutaryl-CoA-reductase). Simvastatin has been shown to reduce both normal and elevated LDL-C concentrations.
	Read more about Simvastatin

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
SIMCARD Film-coated tablet	MPI, Generic	Health Products Regulatory Authority (ZA)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
C10AA01	Simvastatin	C Cardiovascular system → C10 Lipid modifying agents → C10A Lipid modifying agents, plain → C10AA HMG CoA reductase inhibitors
Discover more medicines within C10AA01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
HK	Department of Health Drug Office	49920, 49922
ZA	Health Products Regulatory Authority	36/7.5/0215, 36/7.5/0216, A38/7.5/0372, A38/7.5/0373